Nicholas Buss

Nicholas Buss

Company: Kriya Therapeutics

Job title: VP, Research and Development, Ophthalmology


Translational Safety Endpoints in Nonclinical Studies 11:15 am

Determine key design considerations for AAV nonclinical studies Discuss key endpoints in ocular and CNS gene therapy Evaluate translational review of data for clinical trialsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.